|
 |
|
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Project Summary  Melissa A. Kalarchian, Ph.D. (Young Investigator 2000) of Western Psychiatric Institute and Clinic, will assess the feasibility and effectiveness of a three-month behavioral weight control program for patients treated with clozapine. Although clozapine represents a significant advance in the treatment of schizophrenia, it can cause significant weight gain in patients. This program involves modest caloric restriction and emphasis on regular physical activity. The data from this study will be used to support a larger study with the goal of working toward the development of a comprehensive treatment program. Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia |
Announcements
NARSAD Award Winners
Latest News from NARSAD
|
Mei Huang, Ph.D., Vanderbilt University Medical Center, 2005 & 2007 Young Investigator